Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon.
The trefoil factor TFF3 is a peptide predominantly produced by mucus-secreting cells in the small and large intestines. It has been implicated in intestinal protection and repair. The mechanisms that govern TFF3 secretion are poorly understood. The aim of this study was, therefore, to evaluate the influence of neurotransmitters, hormonal peptides and mediators of inflammation on the release of TFF3. For this purpose, an isolated vascularly perfused rat colon preparation was used. After a bolus administration of 1 ml isotonic saline into the lumen, TFF3 secretion was induced by a 30-min intra-arterial infusion of the compounds to be tested. TFF3 was evaluated in the luminal effluent using a newly developed radioimmunoassay. TFF3 was barely detected in crude luminal samples. In contrast, dithiothreitol (DTT) treatment of the effluent revealed TFF3 immunoreactivity, which amounted to about 0.3 pmol min(-1) cm(-1) in the basal state. Gel chromatography of DTT-treated luminal samples revealed a single peak that co-eluted with the monomeric form of TFF3. TFF3 was not detected in the portal effluent. Bethanechol (10(-6)-10(-4) M), vasoactive intestinal peptide (VIP, 10(-8)-10(-7) M) or bombesin (10(-8)-10(-7) M) induced a dose-dependent release of TFF3. In contrast, substance P evoked a modest release of TFF3, whereas calcitonin gene-related peptide (CGRP), somatostatin, neurotensin or peptide YY (PYY) did not modify TFF3 secretion. The degranulator compound bromolasalocid, 16,16-dimethyl PGE2 (dmPGE2) or interleukin-1-beta (IL-1-beta) also evoked a marked release of TFF3. In conclusion, TFF3 in the colonic effluent is present in a complex. This association presumably involves a disulfide bond. Additionally, the present results suggest a role for enteric nervous system and resident immune cells in mediation of colonic TFF3 secretion.
Moro
F
F
Inserm Unité 45, Hôpital Edouard-Herriot, Pavillon Hbis, 69437 Cedex 03, Lyon, France.
Levenez
F
F
Durual
S
S
Plaisancié
P
P
Thim
L
L
Giraud
A S
AS
Cuber
J C
JC
D015064:16,16-Dimethylprostaglandin E2 / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D018723:Bethanechol / Q000008:administration & dosage / Q000494:pharmacology; D001839:Bombesin / Q000008:administration & dosage / Q000494:pharmacology; D003106:Colon / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D007261:Infusions, Intra-Arterial; D007375:Interleukin-1 / Q000008:administration & dosage / Q000494:pharmacology; D007832:Lasalocid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D009077:Mucins; D009124:Muscle Proteins; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000008:administration & dosage / Q000494:pharmacology; D010455:Peptides; D010477:Perfusion; D011506:Proteins / Q000276:immunology / Q000378:metabolism*; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D000071165:Trefoil Factor-3; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000494:pharmacology
D007375:Interleukin-1; D009077:Mucins; D009124:Muscle Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D010455:Peptides; D011506:Proteins; C082495:TFF3 protein, human; D000071165:Trefoil Factor-3; D018723:Bethanechol; D014660:Vasoactive Intestinal Peptide; D015064:16,16-Dimethylprostaglandin E2; D001839:Bombesin; C029086:bromolasalocid; D007832:Lasalocid